DocSym
β
Searchsearch
Search
(Q62) Congenital obstructive defects of renal pelvis and congenital malformations of ureter
More details coming soon
1 286 489 in individuals diagnosis congenital obstructive defects of renal pelvis and congenital malformations of ureter confirmed
1 908 deaths with diagnosis congenital obstructive defects of renal pelvis and congenital malformations of ureter
Diagnosis congenital obstructive defects of renal pelvis and congenital malformations of ureter is diagnosed Men are 19.32% more likely than Women
767 515
Men receive the diagnosis congenital obstructive defects of renal pelvis and congenital malformations of ureter
1 252 (0.2 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
518 974
Women receive the diagnosis congenital obstructive defects of renal pelvis and congenital malformations of ureter
656 (0.1 %)Died from this diagnosis.
Risk Group for the Disease congenital obstructive defects of renal pelvis and congenital malformations of ureter - Men and Women aged 0
In Men diagnosis is most often set at age 0-89, 95+
Less common in men the disease occurs at Age 90-94Less common in women the disease occurs at Age 85-89, 95+
In Women diagnosis is most often set at age 0-84, 90-94
Disease Features congenital obstructive defects of renal pelvis and congenital malformations of ureter
Absence or low individual and public risk
Congenital obstructive defects of renal pelvis and congenital malformations of ureter - what does this mean
Congenital obstructive defects of renal pelvis and congenital malformations of ureter occur when the development of the ureter and renal pelvis is disrupted, resulting in narrowing or complete obstruction of the ureter and/or the renal pelvis. this can lead to a wide variety of symptoms, including pain, infection, and kidney damage.
What happens during the disease - congenital obstructive defects of renal pelvis and congenital malformations of ureter
Congenital obstructive defects of renal pelvis and congenital malformations of ureter are caused by a combination of genetic and environmental factors. during fetal development, abnormal development of the renal pelvis and ureter can occur due to genetic mutations or environmental exposures. this can lead to narrowing of the renal pelvis and ureter, which can lead to obstruction and can cause a range of symptoms, including pain, fever, and urinary tract infection.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical Examination
- Urine Tests
- Imaging Tests
- Ultrasound
- Computerized Tomography (CT) Scan
- Magnetic Resonance Imaging (MRI) Scan
- Voiding Cystourethrogram (VCUG)
- Ureteral Catheterization
- Renal Scan
- Intravenous Pyelogram (IVP)
- Cystoscopy
Treatment and Medical Assistance
Main goal of the treatment: To reduce or eliminate the obstruction of the renal pelvis and ureter and to prevent further damage to the kidneys.
- Administering medications to reduce inflammation and swelling of the affected area.
- Performing endoscopic procedures to remove or bypass the obstruction.
- Inserting stents to help keep the ureter open.
- Performing surgery to remove the obstruction.
- Conducting imaging studies to monitor the progress of the treatment.
- Administering antibiotics to prevent infection.
- Monitoring kidney function with regular blood and urine tests.
9 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Congenital obstructive defects of renal pelvis and congenital malformations of ureter - Prevention
The prevention of congenital obstructive defects of renal pelvis and congenital malformations of ureter is largely dependent on early detection and management of underlying risk factors. women should be encouraged to seek regular prenatal care to identify any potential risk factors before giving birth. additionally, women should be advised to maintain a healthy lifestyle during pregnancy, including avoiding alcohol and smoking, to reduce the risk of these conditions.